by Truveta staff | Jul 17, 2023 | Data, Technology
Using real-world data to understand a patient’s journey through the healthcare ecosystem can be challenging, particularly for rare or less common diseases. The relevant data are often fragmented, incomplete, and inaccessible—further limiting the data available to...
by Truveta staff | Jun 20, 2023 | Technology
The Centers for Disease Control and Prevention reports that cardiovascular (CV) disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the US, with 805,000 dying yearly. Developing improved cardiovascular therapies is...
by Terry Myerson, CEO | Jun 20, 2023 | Technology
I can’t imagine our country without the FDA continuously assessing the safety and efficacy of medical products, or our government without the CDC monitoring and guiding public health choices. And yet, we all saw during the pandemic that there is a clear opportunity...
by Terry Myerson, CEO | May 30, 2023 | Technology
There is a growing global consensus that “we need to regulate AI”. The most commonly cited suggestion is that we create a new global government agency to issue licenses for developing large AI models. This suggestion is coming from brilliant people thinking big. I...
by Truveta staff | May 19, 2023 | Technology
The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
by Truveta staff | May 5, 2023 | Technology
Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in clinical practice and the related outcomes. Understanding clinical outcomes or adverse events...
